3 ms·
Mounjaro will have FDA approval for obesity this year. GP’s dogmatic stance that “Mounjaro is not an obesity drug!!” is soundly rejected by the available eviden
by runnerup 4y ago
Mounjaro will have FDA approval for obesity this year. GP’s dogmatic stance that “Mounjaro is not an obesity drug!!” is soundly rejected by the available evidence.
- bedast 4y agoMounjaro will never be approved for obesity. The documentation for dosing is for diabetes. If the trend follows with how Novo Nordisk has released their versions of this, dosing for weight loss will be different than dosing for diabetes care, and so it must be under a whole new label. Mounjaro is a trade name for a diabetes drug and that won't change. So no, it is not soundly rejected. It's not as simple as "SQUIRT JUICE INSIDE ME GET THINNER AND CURE DIABETES". There's a lot more to this than you seem to understand.
- m348e912 4y ago>It's not as simple as SQUIRT JUICE INSIDE ME GET THINNER AND CURE DIABETES It kind of is that simple. Tirzepatide has three main functions: Hunger suppression, slower digestion, and increased insulin sensitivity. For a large portion of people who are overweight, this will get them thinner and in some cases reverse t2 diabetes.